SHATTUCK LABS
Shattuck is a clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARC) platform, a novel class of dual-function fusion proteins with applications in oncology and autoimmune disease. The company’s lead program, SL-279252 (PD1-Fc-OX40L), is being studied in a Phase I trial in collaboration with Takeda Pharmaceuticals. Its technology focuses on immuno-oncology research targeted towards patients with many cancer types, including melanoma, lung, and bladder, by endowing one molecule with multiple functions, with applicability across the entire spectrum of human disease that enables medical researchers to find a quick and painless detection of malignancy for later-stage cancer patients.
SHATTUCK LABS
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2016-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.shattucklabs.com
Total Employee:
11+
Status:
Active
Contact:
(917) 892-9996
Email Addresses:
[email protected]
Total Funding:
175.02 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Content Delivery Network JsDelivr AJAX Libraries API Cloudflare Network Error Logging Facebook Domain Insights Zendesk Embeddables Wistia
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Shattuck Labs
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Shattuck Labs
Hatteras Venture Partners
Hatteras Venture Partners investment in Series B - Shattuck Labs
Piper Sandler
Piper Sandler investment in Series B - Shattuck Labs
EcoR1 Capital
EcoR1 Capital investment in Series B - Shattuck Labs
Redmile Group
Redmile Group investment in Series B - Shattuck Labs
Avidity Partners
Avidity Partners investment in Series B - Shattuck Labs
Emerson Collective
Emerson Collective investment in Series B - Shattuck Labs
Partner Fund Management
Partner Fund Management investment in Series B - Shattuck Labs
Key Employee Changes
| Date | New article |
|---|---|
| 2020-02-18 | Shattuck Labs Promotes Dr. Taylor Schreiber to Chief Executive Officer |
Official Site Inspections
http://www.shattucklabs.com
- Host name: 195.97.198.104.bc.googleusercontent.com
- IP address: 104.198.97.195
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Shattuck Labs"
About - Shattuck Labs
Mission & Vision Our vision is to build incredible medicines off the beaten path, by challenging ourselves to think differently. We work with a sense of urgency, focused on scientific …See details»
Shattuck Labs - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (917) 892-9996 Shattuck is a clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARC) …See details»
Shattuck Labs | Shattuck Labs Announces Positive Data from the ...
Feb 20, 2025 – SL-325 is a high-affinity DR3 blocking antibody being developed for the treatment of inflammatory bowel disease (IBD); No evidence of toxicity or residual agonism …See details»
Shattuck Labs Provides Corporate Update and Highlights …
Jan 2, 2025 Abstract accepted for oral presentation at the upcoming 20th European Crohn’s and Colitis Organization Congress, to be held February 19–22, 2025 in Berlin, Germany. …See details»
Shattuck Labs | Investor Relations
Feb 20, 2025 INVESTOR CONTACT. Conor Richardson, CPA, IRC Vice President of Investor Relations. 512-220-1527 [email protected]See details»
Shattuck Labs, Inc. Company Profile | Austin, TX | Competitors ...
Find company research, competitor information, contact details & financial data for Shattuck Labs, Inc. of Austin, TX. Get the latest business insights from Dun & Bradstreet.See details»
Shattuck Labs 2025 Company Profile: Stock Performance
Shattuck Labs General Information Description. Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an …See details»
Shattuck Labs - LinkedIn
Shattuck is a biotechnology company developing a potentially first-in-class antibody for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory autoimmune diseases.See details»
Shattuck Labs - Craft
Oct 28, 2024 Shattuck Labs has 5 employees across 2 locations and $1.66 m in annual revenue in FY 2023. See insights on Shattuck Labs including office locations, competitors, revenue, …See details»
Shattuck Labs - Overview, News & Similar companies - ZoomInfo
Nov 3, 2022 Shattuck Labs contact info: Phone number: (512) 900-4690 Website: www.shattucklabs.com What does Shattuck Labs do? Shattuck Labs, Inc. (NASDAQ: STTK) is …See details»
Working At Shattuck Labs: Company Overview and Culture - Zippia
Www.shattucklabs.com. Organization Type. Public. Social Media. Shattuck is a clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARC™) …See details»
Shattuck Labs, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Shattuck Labs, Inc. of Durham, NC. Get the latest business insights from Dun & Bradstreet.See details»
Shattuck Labs, Inc. Company Profile | Austin, TX | Competitors ...
Address: 500 W 5TH St Ste 1200 Austin, TX, 78701-3835 United States See other locationsSee details»
Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial ...
Dec 31, 2024 – Presented preclinical non-human primate (NHP) data at the 20th Congress of European Crohn’s and Colitis Organization in Inflammatory Bowel Diseases 2025 (ECCO) for …See details»
Shattuck Labs Reports First Quarter 2025 Financial ... - Morningstar
2 days ago – Company advances SL-325 program with an IND filing expected in the third quarter of 2025 – – Cash balance of approximately $60.9 million as of March 31, 2025, …See details»
Shattuck Labs Inc. | North Carolina Biotech Center
Shattuck Labs is a preclinical-stage immunotherapy company focused on utilizing its proprietary ARC (Agonist Redirected Checkpoint) technology to develop novel treatments for use in …See details»
Culture - Shattuck Labs
At Shattuck, we are dedicated to our mission of improving the lives of patients with chronic immune-related diseases. With that vision in mind, we have built a team of innovative …See details»
Who Owns Shattuck Labs – CanvasBusinessModel.com
Dec 19, 2024 Experienced Management Team: The company's leadership team has a wealth of experience in the biotechnology industry, bringing a high level of expertise and strategic vision …See details»
Locations - Shattuck Labs
North Carolina 21 Alexandria Way, Suite 200Durham, NC 27709 Texas 500 W. 5th Street, Suite 1200Austin, TX 78701 Investor Inquiries [email protected] Send Us a …See details»
Shattuck Labs Reports First Quarter 2025 Financial Results and …
1 day ago – Company advances SL-325 program with an IND filing expected in the third quarter of 2025 – – Cash balance of approximately $60.9 million as of March 31, 2025, expected to …See details»